“Clinical Trials & Diverse Communities” Symposium

The “Clinical Trials & Diverse Communities" Symposium will be a half day conference for healthcare and life science executives, professionals, policy makers, and academics to interact, exchange ideas,  and  discuss challenges and opportunities the life science industry face in conducting clinical trials with members of diverse communities. The format will include keynote addresses, panel discussions, and ample time for informal interactions.

The three organizations leading this event have a vision to create the world’s preeminent annual conference focused specifically on the interface between life sciences industry and diverse communities.  Our goals include (i) connecting and networking leading biotechnology and pharmaceutical executives, entrepreneurs, policy officials, researchers, scientists, technologists, academics, and service providers, (ii) creating a collaborative setting for discussing challenges and opportunities of conducting clinical trials with diverse communities, and (iii) exchanging best practices in the life science industries.

The symposium is designed to connect and network leading biotechnology and pharmaceutical executives, entrepreneurs, policy officials, researchers, scientists, technologists, academics, and service providers and create a collaborative setting for discussing challenges and opportunities of conducting clinical trials with diverse communities.

The symposium is complimentary to attend, but space is very limited.  If you would like to attend, RSVP at this site.

Guest Speakers:

• The Honorable Sharon R. Barner, Senior Partner, Foley & Lardner LLP and former Deputy Under Secretary of Commerce for Intellectual Property and Deputy Director of the USPTO at United States Department of Commerce
• Dr. Robert Beltran, Medical Director, Monarch Healthcare and President, Latino Med Policy Institute
• Mr. Laurence Birch, President, Chief Executive Officer, and Chairman of Board, Datatrak International
• Mr. Charles Brummell, President of the Lupus Foundation of America, Illinois Chapter
• Mr. Michel Feldman, Senior Partner, Seyfarth Shaw LLB and Founding Board Member, Watson Pharmaceuticals
• Dr. Owen Garrick, Chief Operating Officer and Director, Bridge Clinical Research Inc.
• Dr. Rick Kittles, Associate Professor in the Department of Medicine and School of Public Health at the University of Illinois at Chicago and Associate Director of Outreach for the UIC Cancer Center